-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Planning GVHD Preemptive Therapy: Risk factors, Biomarkers, and Prognostic Scores

Program: Education Program
Session: Graft Versus Host Disease: Is an Ounce of Prevention Worth a Pound of Cure?
Hematology Disease Topics & Pathways:
Research, clinical trials, Translational Research, assays, Clinical Research, immunology, survivorship, Biological Processes, Technology and Procedures, machine learning, omics technologies, Serologic Tests
Saturday, December 9, 2023, 4:00 PM-5:15 PM

Kirk R. Schultz

University of British Columbia, Vancouver, BC, Canada

Disclosures: No relevant conflicts of interest to declare.

Previous Presentation | Next Presentation >>